Subclinical thyrotoxicosis

被引:63
作者
Marqusee, E [1 ]
Haden, ST [1 ]
Utiger, RD [1 ]
机构
[1] Harvard Univ, Sch Med, Boston, MA USA
关键词
D O I
10.1016/S0889-8529(05)70296-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Subclinical thyrotoxicosis is defined as low serum thyrotropin (TSH) and normal serum thyroid hormone concentrations. It must be distinguished from nonthyroidal illness and secondary hypothyroidism. The most common causes are excessive thyroid hormone therapy, autonomously functioning thyroid adenoma, multinodular goiter, and Graves' disease, but many patients have no evident thyroid disease. A few patients have minor symptoms and signs of hyperthyroidism, The likelihood of progression to overt thyrotoxicosis is low, and many patients have normal serum TSH concentrations weeks or months later. Treatment should be based on consideration of the cause of the subclinical thyrotoxicosis, and whether the patient has any clinical manifestations of thyroid hormone excess or underlying problems likely to be aggravated by small increases in thyroid secretion.
引用
收藏
页码:37 / +
页数:15
相关论文
共 49 条
[1]   Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement [J].
AlAdsani, H ;
Hoffer, LJ ;
Silva, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (04) :1118-1125
[2]   THYROID-DYSFUNCTION IN ADULTS OVER AGE 55 YEARS - A STUDY IN AN URBAN UNITED-STATES COMMUNITY [J].
BAGCHI, N ;
BROWN, TR ;
PARISH, RF .
ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (04) :785-787
[3]   Sensitive thyrotropin and free thyroxine testing in outpatients - Are both necessary? [J].
Bauer, DC ;
Brown, AN .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (20) :2333-2337
[4]   INTERRELATIONSHIPS BETWEEN AGE, THYROID VOLUME, THYROID NODULARITY, AND THYROID-FUNCTION IN PATIENTS WITH SPORADIC NONTOXIC GOITER [J].
BERGHOUT, A ;
WIERSINGA, WM ;
SMITS, NJ ;
TOUBER, JL .
AMERICAN JOURNAL OF MEDICINE, 1990, 89 (05) :602-608
[5]   Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine [J].
Biondi, B ;
Fazio, S ;
Cuocolo, A ;
Sabatini, D ;
Nicolai, E ;
Lombardi, G ;
Salvatore, M ;
Sacca, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (12) :4224-4228
[6]   CONTROL OF ADRENERGIC OVERACTIVITY BY BETA-BLOCKADE IMPROVES THE QUALITY-OF-LIFE IN PATIENTS RECEIVING LONG-TERM SUPPRESSIVE THERAPY WITH LEVOTHYROXINE [J].
BIONDI, B ;
FAZIO, S ;
CARELLA, C ;
SABATINI, D ;
AMATO, G ;
CITTADINI, A ;
BELLASTELLA, A ;
LOMBARDI, G ;
SACCA, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (05) :1028-1033
[7]   CARDIAC EFFECTS OF LONG-TERM THYROTROPIN-SUPPRESSIVE THERAPY WITH LEVOTHYROXINE [J].
BIONDI, B ;
FAZIO, S ;
CARELLA, C ;
AMATO, G ;
CITTADINI, A ;
LUPOLI, G ;
SACCA, L ;
BELLASTELLA, A ;
LOMBARDI, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (02) :334-338
[8]   THYROTROPIN RESULTS IN EUTHYROID PATIENTS WITH A PAST HISTORY OF HYPERTHYROIDISM [J].
BROWNLIE, BEW ;
LEGGE, HM .
ACTA ENDOCRINOLOGICA, 1990, 122 (05) :623-627
[9]   The many causes of subclinical hyperthyroidism [J].
Charkes, ND .
THYROID, 1996, 6 (05) :391-396
[10]   A prospective study of the effect of nonionic contrast media on thyroid function [J].
Conn, JJ ;
Sebastian, MJ ;
Deam, D ;
Tam, M ;
Martin, FIR .
THYROID, 1996, 6 (02) :107-110